Navigation Links
Aratana Therapeutics to Present at Two Upcoming Healthcare Conferences
Date:2/5/2013

KANSAS CITY, Kan. and BOSTON, Feb. 5, 2013 /PRNewswire/ -- Aratana Therapeutics, a biopharmaceutical company developing innovative medicines for cats and dogs (companion animals), today announced that it will present at two upcoming healthcare conferences.  Steven St. Peter , M.D., President and Chief Executive Officer of Aratana Therapeutics, will provide an overview of the Company's business and will be available to participate in one-on-one meetings with potential collaborators. 

Aratana has been selected as one of a few privately held companies to present at the 2013 BIO CEO and Investor Conference, to be held February 11-12, 2013, at the Waldorf Astoria Hotel in New York.  Event:BIO CEO and Investor ConferenceDate: Tuesday, February 12, 2013 Time: 9:45 am (Eastern Time) Location:Park South; Waldorf Astoria Hotel; New YorkThe Company will also present at the Leerink Swann Global Healthcare Conference, to be held February 13-14, 2013, also at the Waldorf Astoria Hotel.  Event:Leerink Swann Global Healthcare ConferenceDate: Thursday, February 14, 2013 Time: 2:30 pm (Eastern Time) Location:Morgan Suite; Waldorf Astoria Hotel; New YorkDr. St. Peter will be joined by Louise Mawhinney , CPA, Chief Financial Officer; Linda Rhodes , V.M.D., Ph.D., Chief Scientific Officer; Julia Stephanus , Chief Commercial Officer; and Erick Lucera , Vice President, Corporate Development of Aratana Therapeutics.About Aratana TherapeuticsAratana Therapeutics is a biopharmaceutical company positioned to deliver high quality new medicines that address significant therapeutic needs for cats and dogs (companion animals).  Aratana licenses and develops proprietary, patent-protected compounds acquired from human pharmaceutical and biotechnology companies and then develops strategies to maximize the value of the programs for the animal health market.  For more information, please visit www.aratanatherapeutics.com.

For Investors & Media:
Joshua Drumm , Ph.D. / Andrew Mielach
Tiberend Strategic Advisors, Inc.
(212) 827-0020
jdrumm@tiberend.com 
amielach@tiberend.com


'/>"/>
SOURCE Aratana Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Aratana Closes $12 Million Series C Financing to Fund Pipeline Expansion
2. Aratana Therapeutics Appoints Erick Lucera Vice President of Corporate Development
3. Aratana to Present at Bank of America Merrill Lynch Animal Health Summit
4. Aratana to Participate in Leerink Swanns November Management Access Days
5. Novelos Therapeutics To Present At The 15th Annual BIO CEO & Investor Conference On February 11
6. Arno Therapeutics, Inc. Appoints Randy Thurman to the Board of Directors
7. Prime Therapeutics named a 2013 National Top Workplace
8. Novelos Therapeutics Presents Diapeutic Technology Platform At EMIT: Targeted Radiotherapy International Conference
9. Cell Therapeutics Announces Data Safety and Monitoring Board Recommendation to Continue the GOG-0212 Phase 3 Clinical Trial of OPAXIOTM as Maintenance Therapy in Ovarian Cancer
10. Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need
11. Prime Therapeutics names Ann Tobin as Chief Compliance Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... , Jan. 20, 2017  Ethicon ... acquired Megadyne Medical Products, Inc., a privately ... and markets electrosurgical tools used in operating ... intelligence of Ethicon,s* advanced energy devices with ... a major step forward in Ethicon,s goal ...
(Date:1/20/2017)... Fla. , Jan. 20, 2017 Wells Specialty ... at 3796 Howell Branch Rd in Winter Park, ... Winter Park . Operations have been consolidated into ... Pharmacy is also pleased to announce that Chad Tomlinson ... President of the Company effective immediately. Mr. Tomlinson is a ...
(Date:1/19/2017)... Jan. 19, 2017 The global immunomodulators ... by 2025, according to a new study by ... to be predominantly driven by high R&D investments ... large-scale production of new and therapeutically advanced drugs. ... drugs at an unprecedented rate into the immunomodulators ...
Breaking Medicine Technology:
(Date:1/21/2017)... , ... January 21, 2017 , ... "ProDOF is the perfect set of tools for ... another subject in a scene," said Christina Austin - CEO of Pixel Film Studios. ... Easily create the illusion of a DSLR racking focus from one area into the ...
(Date:1/21/2017)... ... January 21, 2017 , ... Northern ... has recently joined their multi-specialty medical group. The dermatology practice provides general ... , “We’re excited to add this excellent dermatology practice to our group’s medical ...
(Date:1/20/2017)... ... January 20, 2017 , ... Spectrum Aquatics Launches New ADA Portable Motion Trek BP 300 Lift. ... lift is mounted on wheels, it can be wheeled out of the way and stored ... to the deck. "We have transformed the feedback from customers into specific enhancements and created ...
(Date:1/20/2017)... Boca Raton, FL (PRWEB) , ... January 20, 2017 , ... ... supplement development, announced it attended the January ECRM trade show to continue the marketing ... technologically advanced vitamin C supplement, known for providing 400 percent better absorption than traditional ...
(Date:1/20/2017)... ... January 20, 2017 , ... International Protein, a company based out ... announced it attended the January ECRM trade show in Hilton Head, SC. , ... was determined to create a line of products that would elevate her fitness regime. ...
Breaking Medicine News(10 mins):